Don’t forget needed regulatory guidance changes, the possible expectation of demand created by expanded off label use beyond initial label approval anticipated by Specials usage and preparations needed for true initial demand which may require a more aggressive ramp up plan than initially anticipated. This would align with plans for additional contracted manufacturing services being talked about. While waiting for approval we have also seen guidance in the process of changing and increased leukapheresis capacity being prepared for contractually and by centers being set up by NWBO. Sure seems like a whole lot of preparation for something about to go down especially with the new hire announcement. Best wishes.
Market Data 
Markets 
